phosphodiesterase type num inhibitors vision-threatening adverse events critical analysis review literature pubmed ncbi abstract introduction phosphodiesterase type num pde num inhibitors line drugs treatment erectile dysfunction sildenafil viagra r tadalafil cialis r vardenafil levitra r class drugs inhibit pde num transient visual symptoms change color perception increased light sensitivity well-known adverse effects drugs occur num sildenafil users vision-threatening ocular complications nonarteritic ischemic optic neuropathy cilio-retinal artery occlusion rarely reported pde num inhibitor users aims highlight analyze recently published case literature ocular complications pde num inhibitors methods search peer-reviewed english literature conducted medline databases searched cumulative index nursing allied health literature cochrane library global health md consult causality assessment reported adverse drug reactions analyzed applying world health organization probability scale criteria utilized national registry drug-induced ocular side effects main outcome measures scientifically objectively find pde num inhibitors vision-threatening ocular complications results case reports pde num inhibitor-associated ocular complications identified january num february num case reports included cases anterior posterior nonarteritic ischemic optic neuropathy central retinal vein occlusion cilio-retinal artery occlusion acute angle closure glaucoma optic atrophy sildenafil conclusion lack conclusive evidence direct cause-effect relationship pde num inhibitor vision-threatening ocular events men pde num inhibitors suffer vision-threatening complications frequency general population minor visual adverse effects occur num users transient reversible num international society sexual medicine 
